Sec. 1575.159.  COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST.  A health benefit plan offered under the group program, other than a Medicare Advantage plan or a Medicare prescription drug plan, must provide coverage for a medically accepted prostate-specific antigen test used for the detection of prostate cancer for each male enrolled in the health benefit plan who:
(1)  is at least 50 years of age; or
(2)  is at least 40 years of age and:
(A)  has a family history of prostate cancer; or
(B)  exhibits another cancer risk factor.
Added by Acts 2001, 77th Leg., ch. 1419, Sec. 3, eff. June 1, 2003.
Amended by: 
Acts 2017, 85th Leg., R.S., Ch. 712 (H.B. 3976), Sec. 13, eff. September 1, 2017.